Gyrus Capital
Overview
Gyrus Capital is a Geneva-based private equity firm specializing in transformational investments within the healthcare and sustainability sectors. Founded in 2018, the firm focuses on markets characterized by long-term growth, aiming to deliver efficiency through resilient business models. Gyrus Capital seeks to identify and invest in companies that address structural needs in society and the environment, positioning them for sustainable, long-term growth. The firm's investment strategy emphasizes complex transactions, particularly corporate carve-outs and entrepreneur successions, targeting companies with enterprise values between €50 million and €500 million. Gyrus Capital's sector focus includes healthcare, encompassing pharmaceuticals, medical technology, life sciences, diagnostics, healthcare services, and animal health, as well as sustainability sectors such as digital transformation, automation, energy transition, resource efficiency, and the circular economy. Gyrus Capital's approach is characterized by a partnership model that enables founders and managers to unlock transformational value. The firm has a track record of navigating complex deals, providing solutions to corporates in carve-outs and spin-offs, and actively engaging with management teams to drive change and value creation. Notable investments include the acquisition of a majority stake in ACBC, a leading sustainability service provider in the fashion industry, and the recapitalization of Essential Pharma, a global specialty pharmaceutical group.
Investment Focus
- Companies addressing structural needs in society and the environment
- Enterprise value between €50 million and €500 million
- Positioned for long-term, sustainable growth
Portfolio Companies
Reach Gyrus Capital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Gyrus Capital
What sectors does Gyrus Capital invest in?
Gyrus Capital invests in Healthcare, Life Sciences, Healthcare Services, Diagnostics, Biotech and Sustainability, and is based in Genève, Switzerland. Gyrus Capital is listed as a private equity in the ConnectSafely investor database.
What stage does Gyrus Capital invest at?
Gyrus Capital backs companies at Growth, Buyout, Turnaround and Distressed, writing cheques of 50M - 500M.
Which regions does Gyrus Capital invest in?
Gyrus Capital invests across United States, United Kingdom, Germany, France, Italy and Denmark.
Who are the partners at Gyrus Capital?
Team members listed for Gyrus Capital include Alyson Greenwood (Partner and COO) and Robert Watson (Partner & Co-Founder).
What companies has Gyrus Capital invested in?
Gyrus Capital's portfolio includes ANYbotics, Essential Pharma, ACBC, dss+, Intellera Consulting, Neo Medical, Amazentis and Neurosterix.
How do I contact Gyrus Capital?
Gyrus Capital's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
